SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYPH - Cytoclonal Pharmaceutics -- Ignore unavailable to you. Want to Upgrade?

To: vibaby who wrote (393)12/11/1999 2:13:00 PM
From: Thure Meyer  Read Replies (1) | Respond to of 428
 
Yes,

The volume is abnormal to say the least. I checked the thomsoninvest.net site for their free Autex read out and there was approx. 1/2 institutional and 1/2 retail.
Again, very abnormal.

An information leak is the best explanation. The question now is whether the news is big enough so that its worth taking a position on Monday's opening.

Thure



To: vibaby who wrote (393)1/28/2000 10:29:00 AM
From: Sir Auric Goldfinger  Read Replies (2) | Respond to of 428
 
Horspucky, Vibaby you are once again a victim of a pumpandumporama scheme: "CYTOCLONAL PHARMACEUTICS INC (CYPH)
WIRE TIME Most Recent Item from: DJF Received: Jan/28 9:35 Page 1
1 WSA 0:14 CYTOCLONAL PHAR:JANSSEN PETER FILES TO SELL 9,000 SHARES
2 WSA 0:14 CYTOCLONAL PHAR:JANSSEN PETER FILES TO SELL 4,600 SHARES
3 WSA 0:14 CYTOCLONAL PHAR:JANSSEN PETER FILES TO SELL 6,400 SHARES

Our old friend Peter of DH Blair fame and Dreyfus fame.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News